Fair Value Calculator Fair Value Calculator
EN DE

2585 (2585) Fair Value & Analysis

Consumer Cyclical · Market cap HK$5.5B

2 2585 2585 · HK
PriceHK$20.36
Fair ValueHK$8.25
Upside-59.5%
Quality51/100
Watch 2585 for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range HK$6.18 – HK$10.31

Fair value as of: Jul 2, 2026

From 25 valuation models · updated today

Share price +58.1% over the past month.

Price vs Fair Value (12 months)

HK$25.84 HK$11.92 Fair Value HK$8.25 Jun 2025 Jul 2026

12‑month range HK$11.92 – HK$25.84 · fair‑value band HK$6.18 – HK$10.31 · the HK$20.36 price screens above the HK$8.25 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2585 (2585) currently trades at HK$20.36, while our model-based Fair Value estimate is HK$8.25 — implying the stock looks roughly 59.5% overvalued today. We read business quality at 51/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 2585 generated revenue of HK$20.7B at a net margin of 0.5%. Revenue grew 5.4% year over year. It earns a return on equity of 4.5%. Net debt stands at HK$1.5B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$20.7B
Revenue growth (YoY) +5.4%
Net margin 0.5%
Return on equity 4.5%
Free cash flow HK$42.4M FY2025
P/E ratio 48.5
More key figures
Operating margin 5.7%
EPS (TTM) HK$-0.2600
Dividend yield 1.7%
EPS growth (YoY) +4.1%
Net debt HK$1.5B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

2585 reported revenue of HK$20.7B in FY2025 versus HK$16.9B in FY2021, a compound +5.3%/yr. Reported net income was HK$96.5M in FY2025, compounding −18.7%/yr from FY2021.

Revenue +5.3%/yr
FY21 HK$16.9B
FY22 HK$15.7B
FY23 HK$20.2B
FY24 HK$19.7B
FY25 HK$20.7B
Net income −18.7%/yr
FY21 HK$221M
FY22 HK$181M
FY23 HK$230M
FY24 HK$189M
FY25 HK$96.5M

Is 2585 fairly valued? → Check now

Similar stocks

6 more Luxury Goods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 2585 (2585) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$8.25 versus a price of HK$20.36 — about −59% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 2585?
Our model-based fair value for 2585 is HK$8.25 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$20.36.
What is the quality score of 2585?
2585 has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 2585 (2585)?
2585 reported trailing-twelve-month revenue of about HK$20.7B (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 2585?
The net profit margin of 2585 is about 0.5%, meaning it keeps roughly 0.5% of revenue as net income. Based on the latest reported figures.
Does 2585 pay a dividend?
2585 currently shows a dividend yield of about 1.68% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.